Ion Exchange (india) Ltd. · NSE:IONEXCHANG
Ion Exchange (india) — Q3 FY2020 Earnings Presentation
23 slides from Ion Exchange (india)'s earnings presentation, Jan 27, 2020
Slide 1: Submission of Analyst / Investor Presentation to BSE
• ION EXCHANGE Re-6~~~ tPu, pea_Mt January 27, 2020 To, BSE Limited The Corporate Relationship Dept. P.J. Towers, Dalal Street, Mumbai - 400 001 BSE Company Code: 500214 Dear Sir/ Madam, Sub: Submission of Analyst I Investor Presentation Pursuant to Regulation 30(6) read with Part A of Schedule III
Slide 2: Earnings Presentation | 9M / Q3-FY20
• EARNINGS PRESENTATION | 9M / Q3-FY20 8 ION EXCHANGE R"6~ Uu,p~ 0 0 0
Slide 3: Executive Summary
Executive Summary BUSINESS & REVENUE (%) MIX - OVERVIEW MARQUEE CLIENTS CONSOLIDATED • Ion Exchange (India) Ltd (Ion • Engineering (56%) – Provides • Industrial – NTPC, NPC, Reliance, Exchange), formed in 1964, is a comprehensive and integrated IOCL, JSW, CPCL, L&T, Essar group, pioneer in water, wa
Slide 4: Company Overview
Company Overview • Ion Exchange was originally formed as a subsidiary of Permutit, UK in 1964. REVENUE BREAK UP FY19* It became a wholly owned Indian company in 1985. The company is Consumer currently in its 55th Year of operations. Products 9% • The company has expanded its footprints globally and
Slide 5: 9M / Q3-FY20 Financial Highlights
9M / Q3-FY20 FINANCIAL HIGHLIGHTS Q3-FY20 Performance (Standalone): Q3-FY20 Performance (Consolidated): • Operating Income: INR 3,781 Mn • Operating Income: INR 3,982 Mn • Operating EBITDA: INR 368 Mn • Operating EBITDA: INR 392 Mn • Operating EBITDA Margins: 9.73% • Operating EBITDA Margins: 9.
Slide 6: Q3-FY20 Operational Highlights
Q3-FY20 OPERATIONAL HIGHLIGHTS ENGINNERING Increase in Sales and profitability on the back of healthy order backlog. Sri Lanka order execution is proceeding satisfactorily. Revenue recognition in the quarter is based on work progress. CHEMICALS Sustained demand in certain segments has resulted
Slide 7: Q3-FY20 Standalone Income Statement (IND-AS)
Q3-FY20 STANDALONE INCOME STATEMENT (IND-AS) INCOME STATEMENT (INR MN) Q3-FY20 Q3-FY19 Y-o-Y Q2-FY20 Q-o-Q Operating Income 3,781 2,499 51.3% 3,970 (4.8)% Expenses 3,413 2,308 47.9% 3,674 (7.1)% Operating EBITDA 368 191 92.7% 296 24.3% Operating EBITDA Margins (%) 9.73% 7.64% 209 Bps 7.46% 227 Bps D
Slide 8: Segmental Breakup - Quarterly Standalone
SEGMENTAL BREAKUP - QUARTERLY STANDALONE ENGINEERING (INR MN) CHEMICALS (INR MN) CONSUMER PRODUCTS (INR MN) R 1,300 1,144 350 323 3,200 1,132 E 2,443 1,100 2,700 300 276 V 2,200 900 E 1,700 1,287 250 700 N 1,200 500 200 U 700 E 200 300 150 Q3-FY19 Q3-FY20 Q3-FY19 Q3-FY20 Q3-FY19 Q3-FY20 Q3-FY19 Q3-F
Slide 9: 9M-FY20 Standalone Income Statement (IND-AS)
9M-FY20 STANDALONE INCOME STATEMENT (IND-AS) INCOME STATEMENT (INR MN) 9M-FY20 9M-FY19 Y-o-Y Operating Income 10,793 6,842 57.7% Expenses 9,911 6,433 54.1% Operating EBITDA 882 409 115.6% Operating EBITDA Margins (%) 8.17% 5.98% 219 Bps Depreciation 160 134 19.4% Finance Cost 100 120 (16.7)% Other I
Slide 10: Segmental Breakup - Nine Months Standalone
SEGMENTAL BREAKUP- NINE MONTHS STANDALONE ENGINEERING (INR MN) CHEMICALS (INR MN) CONSUMER PRODUCTS (INR MN) R 8,800 4,000 3,418 1150 E 6,864 2,957 933 6,800 3,000 950 772 V 750 E 4,800 3,543 2,000 550 N 2,800 1,000 350 U E 800 0 150 9M-FY19 9M-FY20 9M-FY19 9M-FY20 9M-FY19 9M-FY20 9M-FY19 9M-FY20 50
Slide 11: Standalone Income Statement (IND AS)
STANDALONE INCOME STATEMENT(IND AS) INCOME STATEMENT (INR MN) FY18 FY19 9M-FY20 Operating Income 9,943 11,023 10,793 Expenses 9,239 10,110 9,911 Operating EBITDA 704 913 882 Operating EBITDA Margins (%) 7.08% 8.28% 8.17% Depreciation 119 181 160 Finance Cost 157 162 100 Other Income 300 441 330 PBT
Slide 12: Standalone Balance Sheet (As per IndAS)
Standalone Balance Sheet (As per IndAS) PARTICULARS (INR MN) FY18 FY19 H1- FY20 PARTICULARS (INR MN) FY18 FY19 H1- FY20 EQUITIES & LIABILITIES ASSETS Equity Non-Current Assets (A) Equity Share Capital 147 147 147 (A) Property, Plant and Equipment 1,347 1,425 1,333 (B) Other Equity 2,987 3,597 3,956
Slide 13: Financials - Standalone
Financials - Standalone REVENUES (INR MN) OPERATING EBITDA (INR MN) PAT (INR MN) 913 GROWTH 11,023 GROWTH GROWTH 666 704 11% 30% 39% 9,943 478 FY18 FY19 FY18 FY19 FY18 FY19 NET DEBT/EQUITY ROE and ROCE WORKING CAPITAL DAYS FY18 FY19 66 16.5% 54 13.5% 17.8% 15.2% (0.4) (0.6) FY18 FY19 FY18 FY19 ROE R
Slide 14: Q3-FY20 Consolidated Income Statement (IND AS)
Q3-FY20 CONSOLIDATED INCOME STATEMENT (IND AS) INCOME STATEMENT (INR MN) Q3-FY20 Q3-FY19 Y-o-Y Q2-FY20 Q-o-Q Operating Income 3,982 2,583 54.2% 4,094 (2.7)% Expenses 3,590 2,396 49.8% 3,765 (4.6)% Operating EBITDA 392 187 109.6% 329 19.1% Operating EBITDA Margins (%) 9.84% 7.24% 260 Bps 8.04% 180 Bp
Slide 15: Segmental Breakup - Quarterly Consolidated
SEGMENTAL BREAKUP-QUARTERLY CONSOLIDATED ENGINEERING (INR MN) CHEMICALS (INR MN) CONSUMER PRODUCTS (INR MN) R 2,600 2,555 1,300 1,233 350 327 323 1,123 E 1,100 300 2,100 V 1,330 900 250 E 1,600 N 1,100 700 200 U 600 500 150 E 100 300 100 Q3-FY19 Q3-FY20 Q3-FY19 Q3-FY20 Q3-FY19 Q3-FY20 Q3-FY19 Q3-FY2
Slide 16: 9M-FY20 Consolidated Income Statement (IND AS)
9M-FY20 CONSOLIDATED INCOME STATEMENT (IND AS) INCOME STATEMENT (INR MN) 9M-FY20 9M-FY19 Y-o-Y Operating Income 11,287 7,305 54.5% Expenses 10,335 6,837 51.2% Operating EBITDA 952 468 103.4% Operating EBITDA Margins (%) 8.43% 6.41% 202 Bps Depreciation 171 145 17.9% Finance Cost 120 142 (15.5)% Othe
Slide 17: Segmental Breakup - Nine Months Consolidated
SEGMENTAL BREAKUP – NINE MONTHS CONSOLIDATED ENGINEERING (INR MN) CHEMICALS (INR MN) CONSUMER PRODUCTS (INR MN) R 7,188 4,000 3,587 934 950 824 E 6,800 3,030 3,000 750 V E 4,800 3,881 2,000 550 N 2,800 1,000 350 U E 800 0 150 9M-FY19 9M-FY20 9M-FY19 9M-FY20 9M-FY19 9M-FY20 9M-FY19 9M-FY20 600 507 55
Slide 18: Consolidated Income Statement (IND-AS)
CONSOLIDATED INCOME STATEMENT(IND-AS) INCOME STATEMENT (INR MN) FY18 FY19 9M-FY20 Operating Income 10,549 11,623 11,287 Expenses 9,779 10,557 10,335 Operating EBITDA 770 1,066 952 Operating EBITDA Margins (%) 7.30% 9.17% 8.43% Depreciation 131 196 171 Finance Cost 187 190 120 Other Income 211 333 24
Slide 19: Consolidated Balance Sheet (IND-AS)
Consolidated Balance Sheet (IND-AS) PARTICULARS (INR MN) FY18 FY19 H1- FY20 PARTICULARS (INR MN) FY18 FY19 H1-FY20 EQUITIES & LIABILITIES ASSETS Equity Non-Current Assets (A) Equity Share Capital 142 142 142 (A) Property, Plant and Equipment 1,436 1,507 1,410 (B) Other Equity 1,859 2,458 2,784 (B) C
Slide 20: Financials - Consolidated
Financials - Consolidated REVENUES (INR MN) OPERATING EBITDA (INR MN) PAT (INR MN) 659 11,623 1,066 10,549 GROWTH GROWTH 770 GROWTH 10% 38% 65% 399 FY18 FY19 FY18 FY19 FY18 FY19 NET DEBT/ EQUITY ROE and ROCE WORKING CAPITAL DAYS 70 FY18 FY19 24.5% 18.3% 55 25.3% 19.9% (0.6) (0.8) FY18 FY19 FY18 FY19
Slide 21: Market Data (Bloomberg – ION IN, Reuters – IONX.BO)
Market Data (Bloomberg – ION IN, Reuters – IONX.BO) 1 YEAR SHARE PRICE MOVEMENT (UPTO 31st DECEMBER, 2019) 150% 100% 50% 0% -50% Jan-19 Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19 Sep-19 Oct-19 Nov-19 Dec-19 Ion Sensex PRICE DATA (AS ON 31st DECEMBER, 2019) SHAREHOLDING PATTERN (AS ON 31st DECE
Slide 22: Disclaimer
Disclaimer Ion Exchange (India) Limited No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all e
Slide 23: Thank You
@ ION EXCHANGE Refreshing the Planet
Ion Exchange (India) — Q3 FY2020 Earnings Presentation on 6ix